Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ISEE | PTGX | COGT | ||
| Company | Iveric Bio Inc | Protagonist Therapeutics Inc | Cogent Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.86 | 88.56 | 38.77 | ||
| High | 39.99 | 91.96 | 39.29 | ||
| Low | 39.85 | 88.34 | 37.86 | ||
| Latest | 39.95 | 91.38 | 39.17 | ||
| Change | +0.15 | +2.82 | +0.64 | ||
| % Change | +0.38% | +3.18% | +1.66% | ||
| Volume | 10,999,100 | 1,308,400 | 2,533,700 | ||
| 20-Day Average Volume | 5,716,510 | 976,775 | 3,499,775 | ||
| Previous Close | 39.80 | 88.56 | 38.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.01 | 86.89 | 37.45 | ||
| 20-Day Raw Stochastic | 98.96% | 86.78% | 61.13% | ||
| 20-Day Relative Strength | 69.12 | 64.77 | 73.23 | ||
| Weighted Alpha | +139.70 | +84.90 | +157.71 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 06/30/23 | +6.17% since 12/03/25 | +0.03% since 12/03/25 | ||
| Low | 39.34 on 07/03/23 | 85.13 on 12/04/25 | 37.86 on 12/10/25 | ||
| High | 39.99 on 07/10/23 | 92.80 on 12/09/25 | 43.73 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +4.80% since 06/09/23 | +9.79% since 11/10/25 | +20.67% since 11/10/25 | ||
| Low | 36.15 on 06/28/23 | 82.06 on 11/14/25 | 28.87 on 11/11/25 | ||
| High | 39.99 on 07/10/23 | 92.80 on 12/09/25 | 43.73 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +46.66% since 04/10/23 | +58.26% since 09/10/25 | +207.22% since 09/10/25 | ||
| Low | 27.23 on 04/11/23 | 57.53 on 09/11/25 | 11.60 on 09/22/25 | ||
| High | 39.99 on 07/10/23 | 93.25 on 10/10/25 | 43.73 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +113.98% since 01/10/23 | +62.11% since 06/10/25 | +427.90% since 06/10/25 | ||
| Low | 18.25 on 01/11/23 | 49.38 on 07/08/25 | 6.88 on 06/13/25 | ||
| High | 39.99 on 07/10/23 | 93.25 on 10/10/25 | 43.73 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,504,431 | 5,536,416 | 5,485,785 | ||
| Shares Outstanding, K | 137,783 | 62,516 | 142,377 | ||
| Annual Sales | 0 | 434,430,000 | 0 | ||
| Annual Net Income | -185,210,000 | 275,190,000 | -255,860,000 | ||
| Last Quarter Sales | 0 | 4,710,000 | 0 | ||
| Last Quarter Net Income | -72,230,000 | -39,340,000 | -80,930,000 | ||
| 60-Month Beta | 1.07 | 2.19 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 05/10/23 | -0.62 on 11/06/25 | -0.50 on 11/07/25 | ||
| Latest Earnings Date | 07/25/23 | 02/20/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 145.56 | 0.00 | ||